My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Volumes jump at Repco Home Finance counter
Sep 29,2016

Repco Home Finance clocked volume of 2.33 lakh shares by 13:55 IST on BSE, a 53.76-times surge over two-week average daily volume of 4,000 shares. The stock fell 1.95% to Rs 802.45.

Solar Industries India notched up volume of 1.06 lakh shares, a 37.30-fold surge over two-week average daily volume of 3,000 shares. The stock fell 1.46% to Rs 638.

Emami saw volume of 2.30 lakh shares, a 24.55-fold surge over two-week average daily volume of 9,000 shares. The stock shed 0.49% to Rs 1,164.95.

Gloster clocked volume of 1.30 lakh shares, a 20.47-fold surge over two-week average daily volume of 6,000 shares. The stock rose 9.96% to Rs 466.95.

Cheviot Company saw volume of 1.02 lakh shares, a 19.36-fold rise over two-week average daily volume of 5,000 shares. The stock rose 5.63% to Rs 1,025.

Powered by Capital Market - Live News

Marksans Pharma corrects on profit booking
Sep 29,2016

Meanwhile, the BSE Sensex was down 258.27 points, or 0.91%, to 28,034.54.

On BSE, so far 32.43 lakh shares were traded in the counter, compared with average daily volume of 8.53 lakh shares in the past one quarter. The stock hit a high of Rs 56.65 and a low of Rs 48 so far during the day. The stock hit a 52-week high of Rs 113.80 on 28 December 2015. The stock hit a 52-week low of Rs 33.45 on 1 March 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, 32.93% compared with 0.18% rise in the Sensex. The scrip had also outperformed the market in past one quarter, 15.34% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 40.93 crore. Face value per share is Re 1.

Shares of Marksans Pharma rose 14.73% in three trading sessions to settle at Rs 54.90 yesterday, 28 September 2016, from its close of Rs 47.85 on Friday, 23 September 2016.

The recent rally in shares of Marksans Pharma was triggered by the company announcing during market hours on Monday , 26 September 2016, that US Food and Drug Administration (USFDA) has granted approval to the company for an Abbreviated New Drug Application (ANDA) for Loratadine liquid filled capsules 10 mg. Loratadine liquid filled capsules 10 mg is therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Healthcare LLC. Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching and other allergy symptoms.

Shares of Marksans Pharma spurted 10.76% to settle at Rs 53 on Monday, 26 September 2016.

Marksans Pharmas consolidated net profit fell 96.76% to Rs 1.02 crore on 11.14% fall in net sales to Rs 186.75 crore in Q1 June 2016 over Q1 June 2015.

Marksans Pharma is engaged in research, manufacturing and marketing of generic pharmaceutical formulation in the global market.

Powered by Capital Market - Live News

United Breweries (Holdings) hits roof after robust Q1 results
Sep 29,2016

The result was announced after market hours yesterday, 28 September 2016.

Meanwhile, the BSE Sensex was down 2.59 points, or 0.01%, to 28,290.22.

On BSE, so far 9.37 lakh shares were traded in the counter, compared with average daily volume of 1.68 lakh shares in the past one quarter. The stock hit a low of Rs 44.65 in intraday trade. The stock hit a 52-week high of Rs 48.70 on 20 September 2016. The stock hit a 52-week low of Rs 18.10 on 30 May 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 43.99% compared with 0.18% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 79.92% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 66.82 crore. Face value per share is Rs 10.

United Breweries (Holdings) is the flagship holding company of the UB Group, through which the promoters and the promoter group hold their stakes in the various companies which comprise the UB Group.

Powered by Capital Market - Live News

Wockhardt gains after UK MHRA completes inspection of Chikalthana plant
Sep 29,2016

The announcement was made during trading hours today, 29 September 2016.

Meanwhile, the BSE Sensex was up 58.98 points, or 0.21%, to 28,351.79.

On BSE, so far 5.92 lakh shares were traded in the counter, compared with average daily volume of 3.17 lakh shares in the past one quarter. The stock hit a high of Rs 945 and a low of Rs 903 so far during the day. The stock hit a 52-week high of Rs 1,748.20 on 2 December 2015. The stock hit a 52-week low of Rs 706.35 on 12 February 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 9.16% compared with 0.18% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 2.90% as against Sensexs 4.79% rise.

The large-cap company has equity capital of Rs 55.27 crore. Face value per share is Rs 5.

Wockhardt announced that inspection of the companys manufacturing unit at L-1, Chikalthana, Aurangabad, Maharashtra by UK Medicines and Healthcare products Regulatory Agency (MHRA) has since been completed without any critical observations and the approval status of the said unit continues.

On a consolidated basis, Wockhardts net profit slumped 82.65% to Rs 15.89 crore on 6.57% decline in net sales to Rs 1064.01 crore in Q1 June 2016 over Q1 June 2015.

Wockhardt is a research based and technology intensive global pharmaceutical and biotechnology company.

Powered by Capital Market - Live News

CEAT advances as Amansa Holding Pte hikes stake
Sep 29,2016

The company made the announcement after trading hours yesterday, 28 September 2016.

Meanwhile, the S&P BSE Sensex, was currently up 74.14 points or 0.26% at 28,366.95

On BSE, so far 2.03 lakh shares were traded in the counter, compared with average daily volume of 1.16 lakh shares in the past one quarter. The stock hit a high of Rs 1,310 and low of Rs 1,263.90 so far during the trading session. The stock had hit record high of Rs 1,318.30 on 7 October 2015. The stock had hit 52-week low of Rs 731.20 on 24 June 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 38.48% compared with 0.18% rise in the Sensex. The scrip had outperformed the market in past one quarter, gaining 48.43% as against Sensexs 4.79% rise.

The mid-cap company has equity capital of Rs 40.45 crore. Face value per share is Rs 10.

Amansa Holding Pte bought 4.75 lakh shares or 1.17% stake in CEAT through secondary market purchase. After the latest stake buy, Amansa Holding Ptes stake in CEAT rose to 5.19%.

CEATs consolidated net profit fell 14.5% to Rs 104.06 crore on 4.04% increase in net sales to Rs 1460.92 crore in Q1 June 2016 over Q1 June 2015.

CEAT is one of Indias leading tyre manufacturers. The company sells its tyres under the CEAT brand.

Powered by Capital Market - Live News

Hindustan Copper declines as OFS for selling govts stake commences
Sep 29,2016

The announcement was made after market hours yesterday, 28 September 2016.

Meanwhile, the BSE Sensex was up 71.68 points, or 0.25%, to 28,364.49.

On BSE, so far 1.37 lakh shares were traded in the counter, compared with average daily volume of 1.76 lakh shares in the past one quarter. The stock hit a high of Rs 63.40 and a low of Rs 62.50 so far during the day. The stock hit a 52-week high of Rs 73.60 on 22 August 2016. The stock hit a 52-week low of Rs 42.30 on 19 February 2016. The stock had underperformed the market over the past 30 days till 28 September 2016, rising 0.15% compared with 0.18% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 22.72% as against Sensexs 4.79% rise.

The mid-cap company has equity capital of Rs 462.61 crore. Face value per share is Rs 5.

The government is offering a 7% stake in the company through a two-day offer for sale (OFS) beginning today, 29 September 2016. The government has set a floor price of Rs 62 per share, a 5.12% discount to the stocks Wednesdays closing share price of Rs 65.35 on BSE.

While the trading window is open for non-institutional investors today, 29 September 2016, retail investors can subscribe tomorrow, 30 September 2016. Retail investors will be allocated shares at a 5% discount to the cut-off price, the company said.

As at 11:15 IST, the OFS received bids for a total of 1.75 crore shares from non-retail investors as against 5.18 crore shares on offer for this category of investors.

The OFS, comprising 6.47 crore shares, will help the government raise Rs 401.54 crore. The governments stake will decline to 82.95% following the sale. The Government of India holds 89.95% stake in Hindustan Copper (as per shareholding pattern as on 30 June 2016).

Hindustan Copper reported net loss of Rs 2.88 crore in Q1 June 2016 as against net profit of Rs 20 crore in Q1 June 2015. Net sales declined 12.2% to Rs 205.99 crore in Q1 June 2016 over Q1 June 2015.

Hindustan Copper is a vertically integrated copper producing company encompassing mining, beneficiation, smelting, refining and casting of refined copper metal.

Powered by Capital Market - Live News

Marathon Nextgen Realty gains as shares begin trading on NSE
Sep 29,2016

Meanwhile, the S&P BSE Sensex was up 73.04 points, or 0.26% to 28,365.85

On BSE, so far 4,713 shares were traded in the counter as against an average daily volume of 10,383 shares in the past one quarter. The stock hit a high of Rs 279 and a low of Rs 262.35 so far during the day. The stock had hit a 52-week high of Rs 297 on 12 August 2016. The stock had hit 52-week low of Rs 107.10 on 30 September 2015. The stock had underperformed the market over the past 30 days till 28 September 2016, falling 4.87% compared with 0.18% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 20.86% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 28.44 crore. Face value per share is Rs 10.

Shares of Marathon Nextgen Realty had gained 10.06% to settle at Rs 263.65 yesterday, 28 September 2016 after the company said that shares of the company will be listed and admitted to dealings on the National Stock Exchange of India with effect from 29 September 2016. The announcement was made during market hours on 28 September 2016.

Marathon Nextgen Realtys consolidated net profit rose 60.11% to Rs 15.05 crore on 86.61% rise in total income to Rs 24.39 crore in Q1 June 2016 over Q1 June 2015.

Marathon Nextgen Realty is a Mumbai-based company engaged in real estate development business.

Powered by Capital Market - Live News

ICICI Prudential Life Insurance Company slips on debut
Sep 29,2016

The stock debuted at Rs 329, a discount of 1.50% to the initial public offer (IPO) price. So far the stock hit a high of Rs 333.90 and low of Rs 315.65. On BSE, so far 39.79 lakh shares were traded on the counter.

ICICI Prudential Life Insurance Company had priced the IPO at the top end of the Rs 300 to Rs 334 price band. The bidding for the IPO concluded on 21 September 2016. The issue received bids for 138.77 crore shares and it was subscribed 10.48 times.

The IPO comprised sale of up to 18.13 crore equity shares of ICICI Prudential, representing about 12.63% of its equity share capital for cash, through an offer for sale (OFS) by ICICI Bank. The entire proceeds from the OFS was paid to ICICI Bank.

Ahead of the IPO, ICICI Prudential raised Rs 1635.33 crore by selling 4.89 crore shares to 38 anchor investors. The shares were allotted to the anchor investors at Rs 334 per share, the top end of the Rs 300 to Rs 334 per share price band for the IPO. Anchor investors allotted shares of ICICI Prudential included Morgan Stanley Mauritius Company, Government of Singapore, UTI Trustee Co, SBI Trustee Co, Birla Sun Life Trustee Company among others.

ICICI Prudential is the largest private sector life insurer in India by total premium and assets under management at 31 March 2016. ICICI Prudential is a joint venture between ICICI Bank and Prudential Corporation Holdings, a part of the Prudential Group, an international financial services group. The company is one of the first private sector life insurance companies in India. It commenced operations in October 2000 and offers a range of life insurance, health insurance and pension products and services.

Powered by Capital Market - Live News

Panacea Biotec gains after announcing shortage of Cilamin 250 Capsule
Sep 29,2016

The announcement was made after market hours yesterday, 28 September 2016.

Meanwhile, the BSE Sensex was up 100.83 points, or 0.36%, to 28,393.64.

On BSE, so far 25,000 shares were traded in the counter, compared with average daily volume of 18,653 shares in the past one quarter. The stock hit a high of Rs 124 and a low of Rs 118.25 so far during the day. The stock hit a 52-week high of Rs 171.20 on 4 December 2015. The stock hit a 52-week low of Rs 83.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 7.29% compared with 0.18% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 6.44% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Re 1.

Panacea Biotec said Cilamin 250 Capsule, used for treatment of Wilsons disease, Rheumatoid Arthritis and other conditions, witnessed short supply in the market during the last few months due to non-availability of raw material D-Penicillamine in India. Panacea Biotec said that its brand Cilamin 250 Capsules has been made available in limited quantities in the retail market. The temporary shortage is due to sudden disruption of supplies of raw material by qualified supplier beyond the control of the company. Since then company has been working tirelessly with alternate suppliers for supply of this raw material. Due to continuous efforts, the company has resumed limited production of Cilamin 250 and have released limited quantities in the market from 26 September 2016 from the companys manufacturing facility at Baddi under Good Manufacturing Practices.

The firm said it continues to work closely with existing and potential new raw material suppliers in China and India for access to the raw material in an accelerated manner. The company said it is in touch with Drug Controller General of India office for allowing imports of raw material in parallel to registration process under this emergency situation to ensure continuous access of this medicine to patients while other alternative sources in India are being also worked upon in an aggressive manner. As per current estimates, the company expects additional 2-4 weeks for access to additional quantities of raw material and additional 4 weeks for Cilamin 250 supplies to normalize.

Panacea Biotec said it is committed to do what all it takes to ensure continuous and sustainable access of good quality Cilamin 250 a critical lifesaving drug to patients.

Panacea Biotec reported net loss of Rs 19.67 crore in Q1 June 2016 as against net loss of Rs 36.90 crore in Q1 June 2015. Net sales declined 0.3% to Rs 120.40 crore in Q1 June 2016 over Q1 June 2015.

Panacea Biotec is one of Indias leading research based biotechnology company established research, manufacturing and marketing capabilities. Panacea Biotec is one of the largest vaccine producer in India and has been amongst the top 3 biotechnology companies and the top 50 pharmaceutical companies in India.

Powered by Capital Market - Live News

L&T gains after winning orders
Sep 29,2016

The announcement was made during trading hours today, 29 September 2016.

Meanwhile, the BSE Sensex was up 146.92 points, or 0.52%, to 28,439.73.

On BSE, so far 9,891 shares were traded in the counter, compared with average daily volume of 1.66 lakh shares in the past one quarter. The stock hit a high of Rs 1,469 and a low of Rs 1,460 so far during the day. The stock hit a 52-week high of Rs 1,615 on 27 July 2016. The stock hit a 52-week low of Rs 1,016.60 on 12 February 2016. The stock had underperformed the market over the past 30 days till 28 September 2016, sliding 1.26% compared with 0.18% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 2.73% as against Sensexs 4.79% rise.

The large-cap company has equity capital of Rs 186.47 crore. Face value per share is Rs 2.

L&T said power transmission a distribution business has won engineering, procurement and construction orders worth Rs 826 crore. Heavy civil infrastructure business has secured a prestigious order worth Rs 675 crore in the metro sector. Building & factories business has bagged a residential project worth Rs 434 crore from a renowned client. Transportation infrastructure business has secured additional orders worth Rs 111 crore in its various ongoing projects.

L&Ts consolidated net profit rose 45.51% to Rs 609.60 crore on 9.33% growth in net sales to Rs 21718.61 crore in Q1 June 2016 over Q1 June 2015.

L&T is a major Indian multinational engaged in technology, engineering, construction, manufacturing and financial services. It operates in more than 30 countries worldwide.

Powered by Capital Market - Live News

Eros International gains after tie up with UAE firm
Sep 29,2016

Meanwhile, the BSE Sensex was up 145.11 points, or 0.51%, to 28,437.92.

On BSE, so far 27,000 shares were traded in the counter, compared with average daily volume of 79,128 shares in the past one quarter. The stock hit a high of Rs 220.50 and a low of Rs 216 so far during the day. The stock hit a 52-week high of Rs 540.90 on 30 September 2015. The stock hit a 52-week low of Rs 125.90 on 29 February 2016. The stock had underperformed the market over the past 30 days till 28 September 2016, falling 4.16% compared with 0.18% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 0.78% as against Sensexs 4.79% rise.

The small-cap company has equity capital of Rs 93.60 crore. Face value per share is Rs 10.

Eros International Media, Indias leading global company in the Indian film industry, announced its association with UAEs largest film distribution and exhibition network (Hollywood & Bollywood), Phars Film. The partnership will entail the two companies jointly co-producing Malayalam films along with exploration of theatrical rights between the two entities. The deal licenses Eros to exploit the distribution of all Malayalam movies produced jointly in India, while Phars Films would present the same overseas where it enjoys a dominant market share.

On a consoldiated basis, net profit of Eros International Media rose 11.20% to Rs 58.87 crore on 13.61% decline in net sales to Rs 408.17 crore in Q1 June 2016 over Q1 June 2015.

Eros International Media operates in the Indian film entertainment industry. It acquires, co-produces and distributes Indian films across all available formats such as cinema, television and digital new media.

Powered by Capital Market - Live News

Arrow Greentech gains after securing patent
Sep 28,2016

The announcement was made during trading hours today, 28 September 2016.

Meanwhile, the BSE Sensex was up 69.11 points, or 0.24%, to 28,292.81

On BSE, so far 7,439 shares were traded in the counter, compared with an average volume of 5,533 shares in the past two weeks. The stock hit a high of Rs 515 and a low of Rs 480 so far during the day. The stock hit a record high of Rs 861 on 23 December 2015. The stock hit a 52-week low of Rs 381.75 on 12 February 2016.

The small-cap company has an equity capital of Rs 11.74 crore. Face value per share is Rs 10.

Arrow Greentech said that the company has received one more United States Patent and Trademark Office (USPTO) patent grant for self destructive irreversible security packaging film from the United States Patent Office on 27 September 2016. The patent was filed through PCT route on 12 September 2006. The invention relates to a self-destructive irreversible security packaging water soluble film and method for manufacturing the same. The water soluble packaging film is embedded with various security elements, and this security feature will get destroyed irreversibly upon final usage as the whole package along with its contents, one the package is dissolved in water. This process of self destruction will control the duplication of package or alteration of the product inside the package. This invention will help in brand protection of many multinational and transnational Agro-Chemical companies, FMCG companies and cosmetic industry. Arrow Greentech hopes that this technology will lead to control of counterfeits and will ultimately benefit the society in the long run. A grant by USPTO means that company can approach the US market with more precision, Arrow Greentech said. In India, this patent has been used since last two years, by the company, it said.

Arrow Greentech (formerly known as Arrow Coated Products) is engaged in manufacturing self-adhesive vinyls, media for large format printing machines, thermal transfer ribbons for bar-coding and bio-degradable water soluble film.

Powered by Capital Market - Live News

Tata Global Beverages gains after Tata Starbucks registers good revenue
Sep 28,2016

The announcement was made after market hours yesterday, 27 September 2016.

Meanwhile, the BSE Sensex was up 73.59 points, or 0.26%, to 28,297.29.

On BSE, so far 6.43 lakh shares were traded in the counter, compared with average daily volume of 2.76 lakh shares in the past one quarter. The stock hit a high of Rs 148.90 and a low of Rs 145.65 so far during the day. The stock hit a 52-week high of Rs 149.80 on 6 January 2016. The stock hit a 52-week low of Rs 100.10 on 12 February 2016. The stock had outperformed the market over the past 30 days till 27 September 2016, rising 4.14% compared with 1.15% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 11.52% as against Sensexs 5.55% rise.

The mid-cap company has equity capital of Rs 63.11 crore. Face value per share is Re 1.

In an an investor presentation, Tata Global Beverages (TGBL) said the growth in Tata Starbucks revenue was led by good in-store performance and expansion of number of stores.

Commenting on leveraging on relationship with Starbucks beyond the Indian market, TGBL said it is looking for supply agreements for other international markets of its Himalayan mineral water brand, which is now available at Starbucks outlets in Singapore.

Tata Starbucks is the 50:50 joint venture (JV) between TGBL and US-based Starbucks Coffee International Inc. The JV operates 84 stores in leading metros such as Delhi, Mumbai, Banagalore, Pune, Hyderabad and Chennai after opening the first store in 2012 in Mumbai.

On a consolidated basis, net profit of Tata Global Beverages rose 51.95% to Rs 119.52 crore on 3.84% rise in net sales to Rs 1711.48 crore in Q1 June 2016 over Q1 June 2015.

Tata Global Beverages focusses on branded natural beverages n++ tea, coffee and water. Tata Global Beverages is the 2nd largest player in branded tea in the world. It has a strong portfolio of brands, including Tata Tea, Tetley, Jemča, Vitax, Eight OClock Coffee, Himalayan, Grand Coffee and Joekels.

Powered by Capital Market - Live News

Volumes jump at Unichem Laboratories counter
Sep 28,2016

Unichem Laboratories clocked volume of 2.58 lakh shares by 15: 15 IST on BSE, a 17.17-times surge over two-week average daily volume of 15,000 shares. The stock rose 2.79% to Rs 273.05.

Apcotex Industries notched up volume of 6.52 lakh shares, a 12.37-fold surge over two-week average daily volume of 53,000 shares. The stock gained 5.07% to Rs 397.05.

Venus Remedies saw volume of 5.12 lakh shares, a 12.09-fold surge over two-week average daily volume of 42,000 shares. The stock rose 20% to Rs 120.05.

Balaji Telefilms clocked volume of 6.60 lakh shares, a 10.23-fold surge over two-week average daily volume of 65,000 shares. The stock jumped 9.26% to Rs 98.50.

Sonata Software saw volume of 4 lakh shares, a 10.14-fold rise over two-week average daily volume of 39,000 shares. The stock rose 5.2% to Rs 164.95.

Powered by Capital Market - Live News

MRF spurts on fresh buying
Sep 28,2016

Meanwhile, the BSE Sensex was up 90.32 points, or 0.32%, to 28,314.02.

On BSE, so far 7,868 shares were traded in the counter, compared with average daily volume of 1,702 shares in the past one quarter. The stock hit a high of Rs 50,000 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 46,701 so far during the day. The stock hit a 52-week low of Rs 30,464.25 on 24 June 2016. The stock had outperformed the market over the past 30 days till 27 September 2016, rising 24.29% compared with 1.15% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 39.63% as against Sensexs 5.55% rise.

The large-cap tyre maker has equity capital of Rs 4.24 crore. Face value per share is Rs 10.

Net profit of MRF rose 2.4% to Rs 490.93 crore on 0.3% rise in net sales to Rs 3462.94 crore in Q1 June 2016 over Q1 June 2015.

MRF manufactures the largest range of tyres in India and exports to various countries worldwide.

Powered by Capital Market - Live News